CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - 10-Q Filing

Charles River Laboratories reports Q3 2026 results with segment performance across Discovery, Manufacturing Support, and Research Models.

SEC EDGAR ·

Tickers: $CRL

Read the full article at SEC EDGAR

More Regulatory news